CLINICAL_TRIALS
trial_result
· 2024-05-03
Clinical Trial Update: A Study of LAM-003 in Patients With Acute Myeloid Leukemia [Phase 1]
Summary
This Phase 1 study of LAM-003 in patients with acute myeloid leukemia has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OrphAI Therapeutics | Conditions: Oncology, Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2024-05-03